The cause for the falsely low advia centaur xp br (assay for ca 27.29) dilution results when compared to the over assay range neat result and the elevated results when the patient sample was treated with heterophile blocking tubes (hbt) and nonspecific binding tubes may be attributed to an interfering substance.The customer's quality control results were within acceptable ranges and there were no other discordant br results reported by the customer for the advia centaur xp br (ca 27.29) assay at the time of the event.The limitations section of the instructions for use states the following: "warning do not use the advia centaur br assay as a screening test or for diagnosis.Normal levels of ca 27.29 do not always preclude the presence of disease.Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays.Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed.Additional information may be required.Note do not interpret levels of ca 27.29 as absolute evidence of the presence or the absence of malignant disease.Before treatment, patients with confirmed breast carcinoma frequently have levels of ca 27.29 within the range observed in healthy individuals.Additionally, elevated levels of ca 27.29 can be observed in patients with nonmalignant diseases.Measurements of ca 27.29 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation." the instrument is operating within specification.
|